Cervical cancer is the fourth most frequent cancer in women with a particularly high burden in low-and middle-income countries(LMICs).
Our commitment to cervical cancer covers the entire screening and triage portfolio for clinicians to identify the person with highest risk among asymptomatic population.
HPV Test
HPV-based screening, which is more sensitive regarding the detection of pre-cancerous lesions compared with cytology-based testing, has been recommended in guidelines issued by WHO and many countries
.
Liquid-Based Cytology Test
Papanicolaou (Pap) test became the primary method to screen for cervical cancer since 1950s and is utilized in many countries worldwide.
Cytology p16/Ki-67 Dual Staining
Meta-analysis showed that p16/Ki-67 duaI staining is much more specific for the detection of CIN3 in women with minor abnormal cytology than HR-HPV testing with acceptable or minimal loss of sensitivity.
|
|
YOUYI Bioscience Ltd.
Right Diagnostics. Real Clinical Value.
Contact Us
Address: Rm 805, Building B1, No.28 Youtian Road, Anliang Community, Yuanshan Sub-district,Longgang District, Shenzhen 518115, Guangdong, P.R.China
Tel: 0755-28262346
Mobile:Shirly Sheng 18071704744
Email: info@youyibio.com